Herborium strives to become the Leader in developing and marketing novel, safe and effective, proprietary botanical therapeutics® (botanical based medicines), and innovative support content which target selected, unmet medical needs for disease treatment, management, and prevention.
The Company’s business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products into Western markets.